Back to the Top 100
Cala Health logo

Rank 68MedTech & Devices

Cala Health

Develops wearable bioelectronic therapies that deliver individualized peripheral nerve stimulation to treat essential tremors.

Visit website
Signal Score
84.9
Total raised
$150M
Stage
Series D+
Founded
2014
Headquarters
San Mateo, USA
Region
North America

Their signal

It stands out as a commercial leader in prescription bioelectronics, offering non-invasive, highly targeted neurological therapies backed by solid peer-reviewed clinical validation.

Signal Score 84.9editorial estimate, see how it is built
Capital (25% weight)88

Total raised, quality of investors and recency of the last round.

Growth (25% weight)82

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)85

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)89

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)80

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in MedTech & Devices

Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.